Lindus Health Secures $55M Series B to Revamp Clinical Trials with Innovative Technology Lindus Health, dubbed the 'anti-CRO', has raised $55 million in Series B funding to revolutionize the clinical trial landscape through technology.

Lindus Health Secures $55M Series B to Revamp Clinical Trials with Innovative Technology #United_States #New_York #Lindus_Health #Balderton_Capital #Citrus_Platform